Illinois Tech Researchers Developing Novel COVID-19 Treatment that Targets Human Spike Protein to Stop Infection
CHICAGO—March 4, 2021—Researchers at Illinois Institute of Technology (Illinois Tech) have been granted a provisional patent for CROWNase—a new drug that has the potential to treat COVID-19 infections...